178 related articles for article (PubMed ID: 19665321)
41. Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.
Suzuki R; Wei X; Allen PK; Welsh JW; Cox JD; Komaki R; Lin SH
Clin Lung Cancer; 2018 Nov; 19(6):e885-e891. PubMed ID: 30197263
[TBL] [Abstract][Full Text] [Related]
42. Outcomes in recurrent small-cell lung cancer after one to four chemotherapy lines: a retrospective study of 300 patients.
Nagy-Mignotte H; Guillem P; Vignoud L; Coudurier M; Vesin A; Bonneterre V; Toffart AC; Sakhri L; Brambilla C; Brambilla E; Timsit JF; Moro-Sibilot D;
Lung Cancer; 2012 Oct; 78(1):112-20. PubMed ID: 22795703
[TBL] [Abstract][Full Text] [Related]
43. Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation.
Rutter CE; Park HS; Corso CD; Yeboa DN; Mancini BR; Lester-Coll NH; Kim AW; Decker RH
Lung Cancer; 2015 Nov; 90(2):243-8. PubMed ID: 26277031
[TBL] [Abstract][Full Text] [Related]
44. Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations.
Han J; Fu C; Li B
Radiat Oncol; 2021 Mar; 16(1):47. PubMed ID: 33663551
[TBL] [Abstract][Full Text] [Related]
45. Limited-stage small cell lung cancer: local failure after chemotherapy and radiation therapy.
Tada T; Minakuchi K; Koda M; Masuda N; Matsui K; Kawase I; Nakajima T; Nishioka M; Fukuoka M; Kozuka T
Radiology; 1998 Aug; 208(2):511-5. PubMed ID: 9680584
[TBL] [Abstract][Full Text] [Related]
46. Utilization of Hyperfractionated Radiation in Small-Cell Lung Cancer and Its Impact on Survival.
Schreiber D; Wong AT; Schwartz D; Rineer J
J Thorac Oncol; 2015 Dec; 10(12):1770-5. PubMed ID: 26334750
[TBL] [Abstract][Full Text] [Related]
47. Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer.
Halvorsen TO; Sundstrøm S; Fløtten Ø; Brustugun OT; Brunsvig P; Aasebø U; Bremnes RM; Kaasa S; Grønberg BH
Acta Oncol; 2016 Nov; 55(11):1349-1354. PubMed ID: 27549509
[TBL] [Abstract][Full Text] [Related]
48. Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer.
Verma V; Simone CB; Allen PK; Gajjar SR; Shah C; Zhen W; Harkenrider MM; Hallemeier CL; Jabbour SK; Matthiesen CL; Braunstein SE; Lee P; Dilling TJ; Allen BG; Nichols EM; Attia A; Zeng J; Biswas T; Paximadis P; Wang F; Walker JM; Stahl JM; Daly ME; Decker RH; Hales RK; Willers H; Videtic GM; Mehta MP; Lin SH
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):362-371. PubMed ID: 28011047
[TBL] [Abstract][Full Text] [Related]
49. Phase II study of everolimus (RAD001) in previously treated small cell lung cancer.
Tarhini A; Kotsakis A; Gooding W; Shuai Y; Petro D; Friedland D; Belani CP; Dacic S; Argiris A
Clin Cancer Res; 2010 Dec; 16(23):5900-7. PubMed ID: 21045083
[TBL] [Abstract][Full Text] [Related]
50. Impact of the Radiation Dose on Survival after Radiochemotherapy for Small-cell Lung Cancer.
Käsmann L; Janssen S; Schild SE; Rades D
Anticancer Res; 2016 Mar; 36(3):1089-91. PubMed ID: 26977003
[TBL] [Abstract][Full Text] [Related]
51. Utilization of prophylactic cranial irradiation in patients with limited stage small cell lung carcinoma.
Giuliani M; Sun A; Bezjak A; Ma C; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
Cancer; 2010 Dec; 116(24):5694-9. PubMed ID: 20803612
[TBL] [Abstract][Full Text] [Related]
52. Analysis of risk factors for pulmonary complications in patients with limited-stage small cell lung cancer : A single-centre retrospective study.
Sas-Korczyńska B; Łuczyńska E; Kamzol W; Sokołowski A
Strahlenther Onkol; 2017 Feb; 193(2):141-149. PubMed ID: 27785518
[TBL] [Abstract][Full Text] [Related]
53. Karnofsky Performance Score, Radiation Dose and Nodal Status Predict Survival of Elderly Patients Irradiated for Limited-disease Small-cell Lung Cancer.
Käsmann L; Janssen S; Rades D
Anticancer Res; 2016 Aug; 36(8):4177-80. PubMed ID: 27466528
[TBL] [Abstract][Full Text] [Related]
54. The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer.
Xia B; Chen GY; Cai XW; Zhao JD; Yang HJ; Fan M; Zhao KL; Fu XL
Radiat Oncol; 2011 May; 6():50. PubMed ID: 21592406
[TBL] [Abstract][Full Text] [Related]
55. [Accelerated fractionation regimens in radiotherapy of inoperable non-small-cell lung cancer].
Val'kov MIu; Zolotkov AG; Mardynskiĭ IuS; Asakhin SM; Kudriavtsev LV; Akishin VA
Vopr Onkol; 2003; 49(5):647-51. PubMed ID: 14682141
[TBL] [Abstract][Full Text] [Related]
56. Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis.
Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Ohe Y; Nishiwaki Y
J Thorac Oncol; 2011 Apr; 6(4):796-800. PubMed ID: 21258253
[TBL] [Abstract][Full Text] [Related]
57. Temporal lung tumor volume changes in small-cell lung cancer patients undergoing chemoradiotherapy.
Yee D; Rathee S; Robinson D; Murray B
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):142-7. PubMed ID: 20646851
[TBL] [Abstract][Full Text] [Related]
58. Is involved-field radiotherapy based on CT safe for patients with limited-stage small-cell lung cancer?
Xia B; Chen GY; Cai XW; Zhao JD; Yang HJ; Fan M; Zhao KL; Fu XL
Radiother Oncol; 2012 Feb; 102(2):258-62. PubMed ID: 22056536
[TBL] [Abstract][Full Text] [Related]
59. [Analysis of treatment outcomes in two patient cohorts (2004-2005 and 2007-2008) with limited and extensive disease small-cell lung cancer].
Hermes A; Waschki B; Gatzemeier U; Reck M
Pneumologie; 2011 Apr; 65(4):203-7. PubMed ID: 21267814
[TBL] [Abstract][Full Text] [Related]
60. Optimal timing of radiotherapy with alternating/sequential radio-chemotherapy for limited-stage small cell lung cancer.
Wang LJ; Liu XJ; Guan Y; Zhang CF; Wang P; Li Y; Guo QS
Asian Pac J Cancer Prev; 2014; 15(14):5697-9. PubMed ID: 25081688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
